Publication | Closed Access

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

Exercise ToleranceHeart FailureCardiovascular DiseaseExerciseExercise PhysiologyCardiovascular PharmacologyPharmacotherapyCardiac CareVasopeptidase InhibitorCardiovascular FunctionCardiovascular ToxicityMedicineCardiologyDiastolic FunctionAnesthesiologyHealth Sciences